|
Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria Clinical research trials and Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria. Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria clinical trial. Subjects often receive the most expert healthcare possible for their Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria  Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
For Condition: Malaria
Status: Recruiting
Sponsor(s): Walter Reed Army Institute of Research (WRAIR) , GlaxoSmithKline Biologicals
Synopsis: This is a double blinded study where 2 test vaccines will be evaluated to see if they protect persons who have never had malaria against malaria infection when bitten by mosquitoes.
Details:
Eligibility:
Study Type: Interventional, Prevention, Randomized, Double-Blind, Active Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/45 Years
Genders: Both
Protocol Entry Criteria: - Be in good general health; not pregnant or planning pregnancy - Have no past history of malaria; no exposure to malaria in past 12 months - Have never received an investigational malaria vaccine - Have no past history of allergic reaction to previous immunization - Have negative blood tests for HIV and specific types of hepatitis - Be able to participate for 4-15 months
Total Enrollment: 104
Location and Contact Information:
Walter Reed Army Institute of Research *Recruiting*
Silver Spring, Maryland, 20910
United States
Recruiting Oman Salazar 866-856-3259
Additional Information:
Study ID Numbers: 1032; 257049/027,Malaria-027
Study Start Date: December 2003
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00075049
Other Malaria Studies:
1. Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
2. Evaluation, Treatment and Monitoring of Patients with a Known or Suspected Parasitic Infection
Related Studies:
Other Malaria Clinical Trials
Other Maryland Clinical Trials
Other Silver Spring Clinical Trials
Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
|
|
|
|
|
|
|
|
